Randhawa Simrat

EVP, Head of R&D at DNTH

Sold, on record
$15M
Dollars the filings state
Form 4 sales
4
Latest Sep 1, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • DNTHDianthus Therapeutics, Inc. /DE/EVP, Head of R&D

Sales by reason

3
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale DNTHRoutine
    Nov 14 2025

    Sold 196,538 shares at $37.55 ($7.4M)

    Randhawa Simrat, EVP, Head of R&D

    10b5-1 planSold 98% of holdings ($7.5M position)4,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale DNTHRoutine
    Mar 12 +118 days

    Sold 33,830 shares at $81.48 ($2.8M)

    Randhawa Simrat, EVP, Head of R&D

    10b5-1 planSold 100% of holdings ($2.8M position)0 shares leftFiling

  3. 3 Form 4 sale DNTHRoutine
    Jun 1 +81 days

    Sold 26,530 shares at $90.62 ($2.4M)

    Randhawa Simrat, EVP, Head of R&D

    10b5-1 planSold 86.9% of holdings ($2.8M position)4,000 shares leftFiling

  4. 4 Form 4 sale DNTHRoutine
    Sep 1 +92 days

    Sold 23,124 shares at $106.41 ($2.5M)

    Randhawa Simrat, EVP, Head of R&D

    10b5-1 planSold 85.3% of holdings ($2.9M position)4,000 shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Randhawa Simrat
Source
Sep 1, 2026DNTHEVP, Head of R&DForm 4 sale23,124$2.5M85.3%RoutineSEC
Jun 1, 2026DNTHEVP, Head of R&DForm 4 sale26,530$2.4M86.9%RoutineSEC
Mar 12, 2026DNTHEVP, Head of R&DForm 4 sale33,830$2.8M100.0%RoutineSEC
Nov 14, 2025DNTHEVP, Head of R&DForm 4 sale196,538$7.4M98.0%RoutineSEC